2m 2m 2m 2m 2m 2m 2m
STOKE THERAP (STOK)
NASDAQ
$27.74+$0.53 (+1.95%)
Price as of Nov 11, 2026 7:30 PM EST- $1.8BMarket Cap
- 8.36%1-Year Change
- BiotechnologyIndustry
STOKE THERAP (STOK)
$27.74+$0.53 (+1.95%)
STOK | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $27.21 | ||
Change | -$0.50 (-1.80%) | ||
Open | $27.55 | ||
High | $28.43 | ||
Low | $26.80 | ||
Previous Close | $27.71 | ||
Volume | 838,276 | ||
30-Day Average Volume | 1,380,035 | ||
1-Week Change | 0.82% | ||
1-Month Change | 9.98% | ||
1-Year Change | 8.36% | ||
3-Year Change | 538.73% | ||
5-Year Change | -4.53% | ||
Fundamentals | |||
Shares Outstanding | 65.4M | ||
Total Assets | $406.7M | ||
Market Cap | $1.8B | ||
Enterprise Value | $1.7B | ||
Period: QTR TTM FY | |||
Revenue | $11.3M | ||
Net Income | -$73.6M | ||
Free Cash Flow | -$65.5M | ||
EBIT | -$73.6M | ||
EBITDA | -$73.2M | ||
Net Working Capital | $305.4M | ||
EPS | -$1.08 | ||
Enterprise Value/EBITDA | -23 | ||
Enterprise Value/Revenue | 149 | ||
P/B | 5 | ||
P/E | -25 | ||
PEG | 2 | ||
Price/Free Cash Flow | -27 | ||
Price/Operating Cash Flow | -28 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue